Speakers Announced for MDMA Annual Meeting

The Medical Device Manufacturers Association (MDMA) 2009 Annual Meeting will take place at the Park Hyatt Washington in Washington, D.C. from June 1-3, 2009. The meeting will bring together executives from innovative medical technology companies and healthcare’s most influential and respected decision makers.

Featured speakers:

Mark McClellan, MD, PhD Director, Engelberg Center for Health Care Reform at the Brookings Institution
Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality
Jo Anne Goodnight, NIH SBIR/STTR Program Coordinator, Director, Division of Special Programs, Office of Extramural Programs, OER, National Institutes of Health, HHS
Mr. Andrew Hirshfeld, Acting Deputy Commissioner for Patent Examination Policy, U.S. Patent and Trademark Office
Timothy Ulatowski, Director, Office of Compliance CDRH, FDA *invited
Joshua M. Sharfstein, MD, Acting Commissioner, U.S. Food and Drug Administration, Department of Health and Human Services *invited

Topics include:

Healthcare Reform in 2009
Improving the US Patent System
Updates from FDA and CMS Officials
International Opportunities and Challenges
Comparative Effectiveness

Registration is $795 for members, $995 for non-members. To register and view the agenda, visit the MDMA website.

The comments are closed.